Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about REGN

Recent news which mentions REGN

< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Looking Into Regeneron Pharmaceuticals's Recent Short Interest
Tickers REGN
Tags Short Ideas Short Sellers Benzinga
From Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth This Much Today
Tickers NEWS REGN
Tags BZI/POD Market News REGN
From Benzinga
Regeneron Pipeline Aims To Address $220 Billion Therapeutic Opportunities By 2030
Tickers NEWS REGN
Tags REGN Benzinga Health Care
From Benzinga
Forecasting The Future: 22 Analyst Projections For Regeneron Pharmaceuticals
Tickers REGN
Tags REGN Benzinga BZI/AAR
From Benzinga
Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
Tickers AMGN BMY GILD LLY
Tags Expert Ideas MRK Biotech
From Benzinga
What Analysts Are Saying About Regeneron Pharmaceuticals Stock
Tickers REGN
Tags Analyst Ratings Market News BZI/AAR
From Benzinga
1 Beaten-Down Stock That Could Soar by 50% in 2025, According to Wall Street
Tickers REGN
Tags Market News REGN Recent Press Releases
From Motley Fool
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
Tickers NEWS REGN
Tags Market News BZI/POD Trading Ideas
From Benzinga
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
Tickers ABBV BMY ELAN GILD
Tags Trading Ideas News Large Cap
From Benzinga
Regeneron's Best-Selling Eye Drug Eylea's Higher Dose Formulation Meets Primary Goal In Another Form Of Retinal Disease Study
Tickers BAYRY NEWS REGN
Tags Briefs BAYRY Market News
From Benzinga
Stocks Slip As Strong November Retail Sales Raise Concerns Over 2025 Fed Rate Cuts
Tickers APA ASML AVGO CEG
Tags QQQ Interest Rates Benzinga
From Benzinga
What 25 Analyst Ratings Have To Say About Regeneron Pharmaceuticals
Tickers REGN
Tags Benzinga REGN Analyst Ratings
From Benzinga
Jim Cramer: This Energy Stock Is A 'Winner,' But Navitas Semiconductor Is 'Losing A Lot Of Money'
Tickers LB LLY NEWS NVTS
Tags Benzinga Media Top Stories
From Benzinga
Regeneron Pharmaceuticals Unusual Options Activity
Tickers REGN
Tags Options Markets Market News
From Benzinga
Regeneron Pharmaceuticals's Options: A Look at What the Big Money is Thinking
Tickers REGN
Tags BZI/UOA REGN Benzinga
From Benzinga
Peering Into Regeneron Pharmaceuticals's Recent Short Interest
Tickers REGN
Tags Trading Ideas Market News BZI/SHORTHIST
From Benzinga
Check Out What Whales Are Doing With REGN
Tickers REGN
Tags Market News Options Markets
From Benzinga
FDA To Revisit Regeneron/Sanofi's Dupixent For Rare Skin Disease
Tickers NEWS REGN SNY
Tags News Large Cap SNY
From Benzinga
28 Analysts Have This To Say About Regeneron Pharmaceuticals
Tickers REGN
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
2 Top Growth Stocks to Buy on the Dip
Tickers LLY REGN
Tags Market News REGN Recent Press Releases
From Motley Fool
Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
Tickers AZN GSK NEWS REGN
Tags General Benzinga Top Stories
From Benzinga
Assessing Regeneron Pharmaceuticals's Performance Against Competitors In Biotechnology Industry
Tickers NEWS REGN
Tags Trading Ideas News REGN
From Benzinga
Is It Time to Buy October's Worst-Performing Nasdaq Stocks?
Tickers ASML DELL IDXX MRNA
Tags ASML Market News SMCI
From Motley Fool
Upstream Bio Is New On NASDAQ, Can Potentially Beat AstraZeneca's Asthma Drug On Efficacy, Analysts Say
Tickers AMGN AZN NEWS REGN
Tags Initiation Expert Ideas AZN
From Benzinga
This Is What Whales Are Betting On Regeneron Pharmaceuticals
Tickers REGN
Tags BZI/UOA Benzinga REGN
From Benzinga
Why Is Regeneron Pharmaceuticals Stock Trading Lower Today?
Tickers NEWS NVO REGN SNY
Tags Briefs Movers NVO
From Benzinga
Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday?
Tickers AAPL AMGN AMZN BKNG
Tags LNG COP MO
From Benzinga
Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights
Tickers ABBV AMGN BIIB BMY
Tags Benzinga Expert Ideas Biotech
From Benzinga
EyePoint's Investigational Drug Shows Early And Sustained Improvement Than Regeneron's Eylea For Diabetes-Associated Vision Loss
Tickers EYPT NEWS REGN
Tags Movers Market News Briefs
From Benzinga
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split
Tickers AMGN CMG GS LLY
Tags NVDA Recent Press Releases GS
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.